Specialty Laboratories launching GenotypR PLUS HIV-1 drug resistance test service through 60 U.S. reps.
This article was originally published in The Gray Sheet
SPECIALTY LABORATORIES, INC. LAUNCHING GENOTYPR PLUS HIV DRUG RESISTANCE TEST SERVICE through 60 direct U.S. sales reps at a cost to physicians of $400 per patient. The reference lab says it is "the first clinically available test to pinpoint resistance-associated HIV mutations for each of the FDA-approved anti-viral drugs."
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.